SEC Form 4 · accession 0001209191-18-005729
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John R Beaver
Officer — SVP & Chief Financial Officer
Period of report
Jan 25, 2018
Accepted (ET)
Jan 26, 2018 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.42 | Jan 25, 2018 | A | 100,000 | A | — | Jan 25, 2028 | Common Stock | 100,000 | 700,000 | D |
Explanation of responses
- F1The stock option vests pro rata monthly over a 36-month period, commencing on February 25, 2018, subject to Mr. Beaver's continued service.